Photo Cred: CDC/Pexels By Katherine Shagoury Two doses of the inactivated novel coronavirus (COVID-19) vaccine, CoronaVac, manufactured by Sinovac, are safe and provoke a strong antibody response among 550 children...
Read MoreThis issue highlights the chronic disease management, with new research, case studies, and integrative patient protocols. Included in this issue: Investigating chronic Lyme disease and coinfections Integrative strategies for supporting...
Read MorePhoto Cred: Robina Weermeijer/Unsplash By Katherine Shagoury New images of a molecule that shuttles omega-3 fatty acids into the brain may open a doorway for delivering neurological therapeutics to the...
Read MorePhoto Cred: Martha Dominguez de Gouveia/Unsplash By Katherine Shagoury Novel coronavirus (COVID-19)-positive patients with traumatic injuries have six times higher risk of death and complication than patients without COVID-19, according...
Read MorePhoto Cred: Anna Shvets/Pexels By Katherine Shagoury A comprehensive molecular study of the brains of people who died of the novel coronavirus (COVID-19) found clear signs of inflammation and impaired...
Read MorePhoto Cred: Unsplash By Katherine Shagoury It is now more than ever crucial for healthcare providers to adopt a self-care practice. In integrative medicine, practitioners frequently prescribe self-care to their...
Read MorePhoto Cred: Mufid Majnun/Unsplash By Katherine Shagoury The Pfizer/BioNTech novel coronavirus (COVID-19) vaccination is “highly effective” against the Delta variant, Reuters reported late last week. The variant, which was first...
Read MorePhoto Cred: Braňo/Unsplash By Katherine Shagoury The novel coronavirus (COVID-19) vaccinations producer by Pfizer/BioNTech and Moderna likely produce an immune response that is strong and potentially long-lasting, according to new...
Read More